CDC42 inhibition suppresses progression of incipient intestinal tumors.
about
MicroRNAs in colorectal carcinoma--from pathogenesis to therapyApproaches of targeting Rho GTPases in cancer drug discoveryCancer Stem Cells and Radioresistance: Rho/ROCK Pathway Plea AttentionClinical relevance of the transcriptional signature regulated by CDC42 in colorectal cancer.Global ablation of the mouse Rab11a gene impairs early embryogenesis and matrix metalloproteinase secretion.miR-18a inhibits CDC42 and plays a tumour suppressor role in colorectal cancer cells.Rab8a vesicles regulate Wnt ligand delivery and Paneth cell maturation at the intestinal stem cell niche.RAB and RHO GTPases regulate intestinal crypt cell homeostasis and enterocyte function.A role for activated Cdc42 in glioblastoma multiforme invasion.A Wntless-SEC12 complex on the ER membrane regulates early Wnt secretory vesicle assembly and mature ligand export.Rho GTPases: Anti- or pro-neoplastic targets?Molecular pathways driving disease-specific alterations of intestinal epithelial cells.Cytotoxic necrotizing factor 1 promotes prostate cancer progression through activating the Cdc42-PAK1 axis.Intestinal GPCRs Control Paneth Cell Maturation and Susceptibility to Experimental Colitis.Using 3D Organoid Cultures to Model Intestinal Physiology and Colorectal Cancer.Inhibition of the RhoGTPase Cdc42 by ML141 enhances hepatocyte differentiation from human adipose-derived mesenchymal stem cells via the Wnt5a/PI3K/miR-122 pathway: impact of the age of the donor.
P2860
Q26766510-D3746365-DC13-4387-A55A-6B88FD6824C4Q26851300-D8D95C95-CDD1-4ECE-AC10-B884A52D9875Q28069232-7F1950C2-CF68-456A-9B13-7B952189B8CCQ33688815-0364BC3D-8092-4545-9CA0-575D58024EC6Q34509747-118B4214-A99C-4BE1-BFEA-880B626821DEQ35402694-2E696831-3F46-489A-B980-B3B716422494Q35791224-C4354BF4-C5BE-478E-8A91-4D05D12A0D75Q36997840-9D741948-8723-43EF-B30C-E88DDC2AB535Q37636732-486D6497-3D1F-4944-8D5C-977736D4E4BCQ38780118-0AE953EA-FA00-4542-8B18-D8C8E2A730B6Q38780866-3CCCE711-B4A8-4950-AF36-FA81CAC4438BQ38953543-F3D3EAAA-ED46-41DD-A869-0AFD31C7B9B2Q40134895-4D53DAE8-E60A-429C-99F6-11416D95F5BDQ42329550-5BF83F50-8FA1-4D9F-AD63-98CEDEB69597Q47669248-D7B573AA-6B96-43AC-91AF-7EAEFE8161DCQ55489971-71095561-0D3F-462B-B1BA-1588CC8B6FF1
P2860
CDC42 inhibition suppresses progression of incipient intestinal tumors.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
CDC42 inhibition suppresses progression of incipient intestinal tumors.
@en
type
label
CDC42 inhibition suppresses progression of incipient intestinal tumors.
@en
prefLabel
CDC42 inhibition suppresses progression of incipient intestinal tumors.
@en
P2093
P2860
P1433
P1476
CDC42 inhibition suppresses progression of incipient intestinal tumors.
@en
P2093
Alexis J Rodriguez
Andrew Hoffman
Chung S Yang
Edward M Bonder
Francesca Walker
Guangxun Li
Jiaxin Sun
Lanlan Shen
P2860
P304
P356
10.1158/0008-5472.CAN-14-0267
P407
P577
2014-08-11T00:00:00Z